The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

OBJECTIVES: Both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and metformin (MET) have markedly antiobesity effects in overweight/obese polycystic ovary syndrome (PCOS) patients. However, there was no literature to compare the antiobesity effects of these two medicines. Therefore, a systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Xiaorui, Lyu, Taibiao, Wang, Xue, Zhu, Huijuan, Pan, Hui, Wang, Linjie, Yang, Hongbo, Gong, Fengying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910049/
https://www.ncbi.nlm.nih.gov/pubmed/33679973
http://dx.doi.org/10.1155/2021/6616693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910049/
https://www.ncbi.nlm.nih.gov/pubmed/33679973
http://dx.doi.org/10.1155/2021/6616693

Ejemplares similares